Calian® Group Ltd. (TSX:CGY), a diverse products and services
company providing innovative healthcare, communications, learning
and cybersecurity solutions, today released its results for the
first quarter ended December 31, 2023.
Q1-24 Highlights:
- Revenue up 21% to $179 million
- Gross margin at 32.5%, up from 30.6% last year
- Adjusted EBITDA1 up 37% to $19.5 million
- Operating free cash flow1 of $14.2 million
- Net liquidity of $139 million
- Repurchased 27,226 shares in consideration of $1.4 million
- Guidance reiterated
- Appointed President, IT & Cyber Solutions
- Completed the acquisition of Decisive Group
|
|
|
|
Financial Highlights |
Three months ended |
(in millions of $, except per
share & margins) |
December 31, |
|
2023 |
|
2022 |
|
% |
|
Revenue |
179.1 |
|
147.5 |
|
21% |
|
Adjusted EBITDA1 |
19.5 |
|
14.3 |
|
37% |
|
Adjusted EBITDA1 % |
10.9% |
|
9.7% |
|
123bps |
|
Net Profit |
5.5 |
|
4.6 |
|
21% |
|
EPS Diluted |
$0.46 |
|
$0.39 |
|
18% |
|
Operating Free Cash Flow1 |
14.2 |
|
12.1 |
|
17% |
|
|
|
|
|
Access the full report on the Calian Financials
web page. Register for the conference call on Thursday, February
15, 2024, 8:00 a.m. Eastern Time.
“We had a strong start to the year with revenues
up 21% driven by double-digit organic growth and the strong
contribution from recent acquisitions,” said Kevin Ford, Calian
Chief Executive Officer. “Steps to restore our efficiency are
bearing fruit with gross margin at an all-time high and adjusted
EBITDA1 margin bordering on 11%. These results demonstrate the
strength of our business model, our diversification into new
markets and offerings as well as the value creation generated from
our M&A agenda. With our guidance reiterated we are on track to
deliver another record year and one step closer to our objective of
reaching one billion dollars by the end of FY26,” stated Mr.
Ford.
First Quarter Results
Revenues increased 21%, from $148 million to
$179 million, driven by growth across all four segments, including
double-digit growth in Health, ITCS and Advanced Technologies.
Acquisitive growth was 9% and was generated by the acquisitions of
Hawaii Pacific Teleport (“HPT”) and Decisive. Organic growth was
12% and was driven by double digit growth in Health and Advanced
Technologies.
Gross margin reached a record 32.5%,
representing its 7th consecutive quarter above 30%. Adjusted
EBITDA1 reached $19.5 million, up 37% over the same period last
year, driven by strong overall revenue growth and margin expansion
in Advanced Technologies and Health, as well as from the benefits
generated from the restructuring plan implemented midway through
the fourth quarter. Adjusted EBITDA1 margin reached 10.9%, up from
9.7% in the same period last year, as a result of a favorable
revenue mix.
Net profit reached $5.5 million, or $0.46 per
diluted share, up from $4.6 million, or $0.39 per diluted share for
the same period last year.
Liquidity and Capital
Resources
“In the first quarter we generated $14.2 million
in operating free cash flow1, representing a 73% conversion rate
from adjusted EBITDA1,” said Patrick Houston, Calian CFO. “We used
our cash and drew on our credit line primarily to invest in our
business with the acquisition of Decisive for $47 million and
capital expenditures of $2 million. We also provided a return to
shareholders in the form of dividends of $3 million and share
buybacks of $1 million. We ended the quarter with $139 million in
net liquidity, well-positioned to pursue our growth objectives,”
concluded Mr. Houston.
Normal Course Issuer Bid
In the three-month period ended December 31,
2023, as part of its Normal Course Issuer Bid, the Company
repurchased 27,226 shares for cancellation in consideration of $1.4
million. Since the launch of the Normal Course Issuer Bid on
September 1, 2023, the Company repurchased 59,320 common shares for
cancellation in consideration of $3.0 million.
Quarterly Dividend
Today, Calian declared a quarterly dividend of
$0.28 per share. The dividend is payable March 13, 2024, to
shareholders of record as of February 28, 2024. Dividends paid by
the Corporation are considered “eligible dividend” for tax
purposes.
|
|
|
|
Guidance Reiterated |
|
|
|
|
|
|
|
|
Guidance for the year ended September 30,
2024 |
|
|
|
|
(in thousands of Canadian $) |
Low |
|
High |
Revenue |
730,000 |
|
790,000 |
Adjusted EBITDA1 |
83,000 |
|
89,000 |
This guidance does not include any acquisitions
that may close within the fiscal year. The guidance reflects
another record year for the Company and positions it well to
achieve its long-term growth targets.
Management Update
Recently, Patrick Thera, President Advanced
Technologies, informed Calian that he will be retiring after a
38-year career with SED Systems and Calian. “Patrick played a
pivotal role in shaping the success of the Advanced Technologies
segment. I am immensely grateful for his dedication, sage counsel
and commitment to the business. He will remain at the helm of the
segment while we conduct a search for his successor and provide a
smooth transition,” said Kevin Ford, Calian Chief Executive
Officer.
1 This is a non-GAAP measure. Please refer to
the section “Reconciliation of non-GAAP measures to most comparable
IFRS measures” at the end of the press release. About
Calian
We keep the world moving forward. Calian® helps
people communicate, innovate, learn and lead safe and healthy
lives. Every day, our employees live our values of customer
commitment, integrity, innovation, respect and teamwork to engineer
reliable solutions that solve complex problems. That’s Confidence.
Engineered. A stable and growing 40-year company, we are
headquartered in Ottawa with offices and projects spanning North
American, European and international markets.
Visit calian.com to learn about innovative
healthcare, communications, learning and cybersecurity
solutions.
Product or service names mentioned herein may be
the trademarks of their respective owners.
Media inquiries:pr@calian.com 613-599-8600 x 2298
Investor Relations inquiries:ir@calian.com
DISCLAIMER
Certain information included in this press
release is forward-looking and is subject to important risks and
uncertainties. The results or events predicted in these statements
may differ materially from actual results or events. Such
statements are generally accompanied by words such as “intend”,
“anticipate”, “believe”, “estimate”, “expect” or similar
statements. Factors which could cause results or events to differ
from current expectations include, among other things: the impact
of price competition; scarce number of qualified professionals; the
impact of rapid technological and market change; loss of business
or credit risk with major customers; technical risks on fixed price
projects; general industry and market conditions and growth rates;
international growth and global economic conditions, and including
currency exchange rate fluctuations; and the impact of
consolidations in the business services industry. For additional
information with respect to certain of these and other factors,
please see the Company’s most recent annual report and other
reports filed by Calian with the Ontario Securities Commission.
Calian disclaims any intention or obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise. No assurance can be given
that actual results, performance or achievement expressed in, or
implied by, forward-looking statements within this disclosure will
occur, or if they do, that any benefits may be derived from
them.
Calian · Head Office · 770 Palladium Drive ·
Ottawa · Ontario · Canada · K2V 1C8 Tel: 613.599.8600 · Fax:
613-592-3664 · General info email: info@calian.com
|
CALIAN GROUP LTD. |
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF
FINANCIAL POSITION |
|
As at December 31, 2023 and September 30,
2023 |
(Canadian dollars in thousands, except per share
data) |
|
|
|
|
|
|
|
|
|
December 31, |
|
September 30, |
|
|
2023 |
|
2023 |
ASSETS |
|
|
|
|
|
|
CURRENT ASSETS |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
52,267 |
|
|
$ |
33,734 |
Accounts receivable |
|
|
185,150 |
|
|
|
173,052 |
Work in process |
|
|
17,478 |
|
|
|
16,580 |
Inventory |
|
|
28,585 |
|
|
|
21,983 |
Prepaid expenses |
|
|
22,128 |
|
|
|
19,040 |
Derivative assets |
|
|
40 |
|
|
|
155 |
Total current assets |
|
|
305,648 |
|
|
|
264,544 |
NON-CURRENT ASSETS |
|
|
|
|
|
|
Property, plant and equipment |
|
|
38,320 |
|
|
|
37,223 |
Right of use assets |
|
|
36,110 |
|
|
|
34,637 |
Prepaid expenses |
|
|
9,690 |
|
|
|
10,386 |
Deferred tax asset |
|
|
1,034 |
|
|
|
967 |
Investments |
|
|
3,673 |
|
|
|
3,673 |
Acquired intangible assets |
|
|
118,318 |
|
|
|
75,160 |
Goodwill |
|
|
190,485 |
|
|
|
159,133 |
Total non-current assets |
|
|
397,630 |
|
|
|
321,179 |
TOTAL ASSETS |
|
$ |
703,278 |
|
|
$ |
585,723 |
LIABILITIES AND
SHAREHOLDERS’ EQUITY |
|
|
|
|
|
|
CURRENT LIABILITIES |
|
|
|
|
|
|
Debt facility |
|
$ |
93,750 |
|
|
$ |
37,750 |
Accounts payable and accrued liabilities |
|
|
132,159 |
|
|
|
105,550 |
Provisions |
|
|
2,593 |
|
|
|
2,848 |
Unearned contract revenue |
|
|
41,587 |
|
|
|
32,423 |
Lease obligations |
|
|
5,156 |
|
|
|
4,949 |
Contingent earn-out |
|
|
26,697 |
|
|
|
11,263 |
Derivative liabilities |
|
|
141 |
|
|
|
353 |
Total current liabilities |
|
|
302,083 |
|
|
|
195,136 |
NON-CURRENT LIABILITIES |
|
|
|
|
|
|
Lease obligations |
|
|
33,571 |
|
|
|
32,057 |
Unearned contract revenue |
|
|
14,850 |
|
|
|
15,592 |
Contingent earn-out |
|
|
2,603 |
|
|
|
2,535 |
Deferred tax liabilities |
|
|
20,597 |
|
|
|
12,031 |
Total non-current liabilities |
|
|
71,621 |
|
|
|
62,215 |
TOTAL LIABILITIES |
|
|
373,704 |
|
|
|
257,351 |
|
|
|
|
|
|
|
SHAREHOLDERS’ EQUITY |
|
|
|
|
|
|
Issued capital |
|
|
227,466 |
|
|
|
225,540 |
Contributed surplus |
|
|
4,279 |
|
|
|
4,856 |
Retained earnings |
|
|
98,234 |
|
|
|
96,859 |
Accumulated other comprehensive income (loss) |
|
|
(405 |
) |
|
|
1,117 |
TOTAL SHAREHOLDERS’ EQUITY |
|
|
329,574 |
|
|
|
328,372 |
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
$ |
703,278 |
|
|
$ |
585,723 |
Number of common shares issued
and outstanding |
|
|
11,834,924 |
|
|
|
11,812,650 |
The accompanying notes are an integral part of
the unaudited interim condensed consolidated financial
statements.
|
CALIAN GROUP LTD. |
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF NET
PROFIT |
For the three months ended December 31, 2023 and
2022 |
(Canadian dollars in thousands, except per share
data) |
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
December 31, |
|
|
2023 |
|
2022 |
Revenue |
|
$ |
179,179 |
|
$ |
147,543 |
Cost of revenues |
|
|
120,961 |
|
|
102,324 |
Gross
profit |
|
|
58,218 |
|
|
45,219 |
|
|
|
|
|
|
|
Selling and marketing |
|
|
12,351 |
|
|
11,143 |
General and administration |
|
|
23,634 |
|
|
17,400 |
Research and development |
|
|
2,719 |
|
|
2,421 |
Profit before under noted
items |
|
|
19,514 |
|
|
14,255 |
|
|
|
|
|
|
|
Depreciation of property, plant
and equipment |
|
|
2,308 |
|
|
2,297 |
Depreciation of right of use
assets |
|
|
1,463 |
|
|
1,007 |
Amortization of acquired
intangible assets |
|
|
5,235 |
|
|
3,361 |
Deemed compensation |
|
|
604 |
|
|
97 |
Changes in fair value related to contingent earn-out |
|
|
726 |
|
|
742 |
Profit before interest
income and income tax expense |
|
|
9,178 |
|
|
6,751 |
|
|
|
|
|
|
|
Interest expense |
|
|
1,547 |
|
|
123 |
Income tax expense |
|
|
2,106 |
|
|
2,052 |
NET PROFIT |
|
$ |
5,525 |
|
$ |
4,576 |
|
|
|
|
|
|
|
Net profit per
share: |
|
|
|
|
|
|
Basic |
|
$ |
0.47 |
|
$ |
0.39 |
Diluted |
|
$ |
0.46 |
|
$ |
0.39 |
The accompanying notes are an integral part of
the unaudited interim condensed consolidated financial
statements.
|
CALIAN GROUP LTD. |
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH
FLOWS |
For the three months ended December 31, 2023 and
2022 |
(Canadian dollars in thousands) |
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
December 31, |
|
|
2023 |
|
|
2022 |
|
CASH FLOWS GENERATED FROM (USED
IN) OPERATING ACTIVITIES |
|
|
|
|
|
|
Net profit |
|
$ |
5,525 |
|
|
$ |
4,576 |
|
Items not affecting cash: |
|
|
|
|
|
|
Interest expense |
|
|
1,098 |
|
|
|
12 |
|
Changes in fair value related to contingent earn-out |
|
|
726 |
|
|
|
742 |
|
Lease obligations interest expense |
|
|
449 |
|
|
|
111 |
|
Income tax expense |
|
|
2,106 |
|
|
|
2,052 |
|
Employee share purchase plan expense |
|
|
162 |
|
|
|
163 |
|
Share based compensation expense |
|
|
1,013 |
|
|
|
407 |
|
Depreciation and amortization |
|
|
9,006 |
|
|
|
6,665 |
|
Deemed compensation |
|
|
604 |
|
|
|
97 |
|
|
|
|
20,689 |
|
|
|
14,825 |
|
Change in non-cash working
capital |
|
|
|
|
|
|
Accounts receivable |
|
|
(11,189 |
) |
|
|
34,714 |
|
Work in process |
|
|
(898 |
) |
|
|
6,825 |
|
Prepaid expenses and other |
|
|
(74 |
) |
|
|
3,664 |
|
Inventory |
|
|
(2,590 |
) |
|
|
(7,965 |
) |
Accounts payable and accrued liabilities |
|
|
15,516 |
|
|
|
(27,268 |
) |
Unearned contract revenue |
|
|
206 |
|
|
|
2,429 |
|
|
|
|
21,660 |
|
|
|
27,224 |
|
Interest paid |
|
|
(1,547 |
) |
|
|
(123 |
) |
Income tax paid |
|
|
(2,575 |
) |
|
|
(1,778 |
) |
|
|
|
17,538 |
|
|
|
25,323 |
|
CASH FLOWS GENERATED FROM (USED
IN) FINANCING ACTIVITIES |
|
|
|
|
|
|
Issuance of common shares net of costs |
|
|
694 |
|
|
|
910 |
|
Dividends |
|
|
(3,314 |
) |
|
|
(3,262 |
) |
Draw on debt facility |
|
|
56,000 |
|
|
|
- |
|
Payment of lease obligations |
|
|
(1,171 |
) |
|
|
(1,009 |
) |
Repurchase of common shares |
|
|
(1,357 |
) |
|
|
- |
|
|
|
|
50,852 |
|
|
|
(3,361 |
) |
CASH FLOWS USED IN INVESTING
ACTIVITIES |
|
|
|
|
|
|
Investments |
|
|
- |
|
|
|
(2,689 |
) |
Business acquisitions |
|
|
(47,457 |
) |
|
|
(2,925 |
) |
Property, plant and equipment |
|
|
(2,400 |
) |
|
|
(800 |
) |
|
|
|
(49,857 |
) |
|
|
(6,414 |
) |
|
|
|
|
|
|
|
NET CASH INFLOW |
|
$ |
18,533 |
|
|
$ |
15,548 |
|
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD |
|
|
33,734 |
|
|
|
42,646 |
|
CASH AND CASH EQUIVALENTS, END OF PERIOD |
|
$ |
52,267 |
|
|
$ |
58,194 |
|
The accompanying notes are an integral part of
the unaudited interim condensed consolidated financial
statements.
RECONCILIATION OF NON-GAAP MEASURES TO
MOST COMPARABLE IFRS MEASURES
The following non-GAAP measures are mainly
derived from the consolidated financial statements, but do not have
a standardized meaning prescribed by IFRS; therefore, others using
these terms may calculate them differently. The exclusion of
certain items from non-GAAP performance measures does not imply
that these are necessarily nonrecurring. From time to time, we may
exclude additional items if we believe doing so would result in a
more transparent and comparable disclosure. Other entities may
define these measures differently than we do. In those cases, it
may be difficult to use similarly named non-GAAP measures of other
entities to compare performance of those entities to the Company’s
performance.
Management believes that providing certain
non-GAAP performance measures, in addition to IFRS measures,
provides users of the Company’s financial reports with enhanced
understanding of the Company’s results and related trends and
increases transparency and clarity into the core results of the
business. Adjusted EBITDA excludes items that do not reflect, in
our opinion, the Company’s core performance and helps users of our
MD&A to better analyze our results, enabling comparability of
our results from one period to another.
|
Adjusted
EBITDA |
|
|
|
|
|
|
|
|
Three months ended |
|
|
December 31, |
|
December 31, |
|
|
2023 |
|
2022 |
Net profit |
|
$ |
5,525 |
|
$ |
4,576 |
Depreciation of equipment and
application software |
|
|
2,308 |
|
|
2,297 |
Depreciation of right of use
asset |
|
|
1,463 |
|
|
1,007 |
Amortization of acquired
intangible assets |
|
|
5,235 |
|
|
3,361 |
Interest expense |
|
|
1,547 |
|
|
123 |
Changes in fair value related to
contingent earn-out |
|
|
726 |
|
|
742 |
Deemed Compensation |
|
|
604 |
|
|
97 |
Income tax |
|
|
2,106 |
|
|
2,052 |
Adjusted EBITDA |
|
$ |
19,514 |
|
$ |
14,255 |
Operating Free Cash
Flow |
|
|
|
|
|
|
|
|
Three months ended |
|
|
December 31, |
|
December 31, |
|
|
2023 |
|
2022 |
|
|
|
|
|
|
|
Cash flows generated from operating activities |
|
$ |
17,538 |
|
|
$ |
25,323 |
|
Property, plant and equipment |
|
|
(2,400 |
) |
|
|
(800 |
) |
Free cash flow |
|
$ |
15,138 |
|
|
$ |
24,523 |
|
|
|
|
|
|
|
|
Free cash flow |
|
$ |
15,138 |
|
|
$ |
24,523 |
|
Adjustments: |
|
|
|
|
|
|
Change in non-cash working capital |
|
|
(971 |
) |
|
|
(12,399 |
) |
Operating free cash flow |
|
$ |
14,167 |
|
|
$ |
12,124 |
|
Operating free cash flow per
share |
|
|
1.20 |
|
|
|
1.04 |
|
Operating free cash flow conversion |
|
|
73% |
|
|
|
85% |
|
Operating free cash flow measures the company’s
cash profitability after required capital spending when excluding
working capital changes. The Company’s ability to convert adjusted
EBITDA to operating free cash flow is critical for the long term
success of its strategic growth. These measurements better align
the reporting of our results and improve comparability against our
peers. We believe that securities analysts, investors and other
interested parties frequently use non-GAAP measures in the
evaluation of issuers. Management also uses non-GAAP measures in
order to facilitate operating performance comparisons from period
to period, prepare annual operating budgets and assess our ability
to meet our capital expenditure and working capital requirements.
Non-GAAP measures should not be considered a substitute for or be
considered in isolation from measures prepared in accordance with
IFRS. Investors are encouraged to review our financial statements
and disclosures in their entirety and are cautioned not to put
undue reliance on non-GAAP measures and view them in conjunction
with the most comparable IFRS financial measures.
Calian (TSX:CGY)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Calian (TSX:CGY)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024